Drawing for SCALDEX

USPTO serial 76347176

SCALDEX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
POWELL, LINDA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SCALDEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JAMES R MENKER

JAMES R MENKER PILLSBURY WINTHROP LLPPO BOX 10500MCLEAN, VA 22102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics; aromatic oils, namely, perfume oils and aromatherapy oils; dyes for cosmetic purposes, namely, hair dye; disposable wipes impregnated with cosmetic liquid for personal hygiene; preparations for make-up cleaning, namely, make-up remover; depilatories; incenses; deodorants; perfumes; cosmetic preparations for baths, namely, bath foam and gel; nail lacquers; cosmetic creams; cosmetic masks; cosmetic ointments; soaps; body and facial lotions; cosmetic milks; body oils; cosmetic pencils; tooth paste; shampoos; sun block preparations; sun screen preparations; sun tanning preparations; lipsticks; makeup powders; cosmetic preparations for eyelashes; creams and preparations for skin; shampoos; cosmetic agents for lips, namely, lip cream; hair paints; preparations for hair modeling; eau de cologne; toilet waters; cosmetic talc; and balsamsACTIVE—
005Medicines for medical purposes, namely, allergy medications, acne medications, burn relief medication, diarrhea medications, fungal medications and pain relief; pharmaceuticals, namely, lipid lowering agents; medical materials, namely, bandages for skin wounds and mole skin for use as a medical bandage; biological preparations for the treatment of burns and scalds; chemical preparations for the treatment of burns and scalds; herbal teas for medicinal purposes; synthetic, natural and mixed pharmaceutical agents and preparations for the treatment of burns and scalds; pharmaceutical preparations, namely, antitussive-cold preparations, anticoagulants, antidepressants, appetite suppressants; pharmaceutical preparations for use in chemotherapy; ointments, namely, antibiotic ointments, anti-itch ointments, hemorrhoid ornaments and medical diaper rash ointments; liniments; therapeutic preparations for remedial baths, namely, bath salts for medical purposes; medicated skin lotions; medicated hair lotions; medication facial lotions, medicated body lotions; aerosols for the treatment of burns and scalds; herbal tincture for the treatment of burns and scalds; dietary drink mix for use as a meal replacement; diet pills; medical agents to prevent sweating; pain killers; medicated lotions to protect against sunburns; cough syrups; sleeping pills; antipyretics; sedatives; fats for the treatment of burns and scalds; herbal supplements; gelatin capsules sold empty for pharmaceuticals; food for medically restricted diets and vitaminsACTIVE—
035preparing and placing advertisements for others; retail store services and on-line retail store services featuring cosmetics, toiletries, pharmaceuticals and medicinal products; and retail pharmacy servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 28, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 28, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 18, 2004EX3GSOU EXTENSION 3 GRANTED—
Oct 20, 2004EXT3SOU EXTENSION 3 FILED—
Oct 20, 2004MAILPAPER RECEIVED—
Oct 19, 2004DOCKASSIGNED TO EXAMINER—
May 14, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 5, 2004EX2GSOU EXTENSION 2 GRANTED—
May 3, 2004CFITCASE FILE IN TICRS—
May 3, 2004CFITCASE FILE IN TICRS—
Apr 21, 2004EXT2SOU EXTENSION 2 FILED—
Apr 21, 2004MAILPAPER RECEIVED—
Nov 6, 2003EX1GSOU EXTENSION 1 GRANTED—
Oct 9, 2003EXT1SOU EXTENSION 1 FILED—
Oct 9, 2003MAILPAPER RECEIVED—
Apr 29, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 4, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 15, 2003NPUBNOTICE OF PUBLICATION—
Nov 21, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 30, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 30, 2002MAILPAPER RECEIVED—
Mar 29, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance